# Hypofractionated Chemoradiotherapy for Cervical Cancer

> **NCT07709650** · PHASE3 · RECRUITING · sponsor: **Mahidol University** · enrollment: 250 (estimated)

## Conditions studied

- Cervival Cancer

## Interventions

- **RADIATION:** Hypofractionated Chemoradiotherapy
- **RADIATION:** Conventional Chemoradiotherapy
- **DRUG:** Concurrent chemotherapy

## Key facts

- **NCT ID:** NCT07709650
- **Lead sponsor:** Mahidol University
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2026-08-03
- **Primary completion:** 2031-06
- **Final completion:** 2033-06
- **Target enrollment:** 250 (ESTIMATED)
- **Last updated:** 2026-08-24

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07709650

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07709650, "Hypofractionated Chemoradiotherapy for Cervical Cancer". Retrieved via MORVS 2026-10-20 from https://api.morvs.ai/clinical/NCT07709650. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*